Challine Dominique, Pellegrin Bertrand, Bouvier-Alias Magali, Rigot Pierrette, Laperche Liliane, Pawlotsky Jean-Michel
Viral Emergency and Organ, Tissue, and Cell Donor Screening Laboratory, Department of Virology (INSERM U635), Hôpital Henri Mondor, Université Paris XII, Créteil, France.
Lancet. 2004;364(9445):1611-2. doi: 10.1016/S0140-6736(04)17315-7.
The objective of our study was to determine whether nucleic acid testing could detect HIV RNA or hepatitis C virus (HCV) RNA in a large series of seronegative organ and tissue donors, and whether this technique should be routinely used to improve viral safety of grafts. We studied 2236 organ donors, 636 tissue donors, and 177 cornea donors. We identified five HCV RNA-positive donors in 2119 HCV-seronegative organ donors, and one HCV RNA-positive donor in 631 HCV-seronegative tissue donors. No HIV-seronegative, HIV RNA-positive donor was identified. Our data suggest that routine nucleic acid testing of organ and tissue donors might increase viral safety in transplantation.
我们研究的目的是确定核酸检测能否在大量血清学阴性的器官和组织供体中检测到HIV RNA或丙型肝炎病毒(HCV)RNA,以及该技术是否应常规用于提高移植物的病毒安全性。我们研究了2236名器官供体、636名组织供体和177名角膜供体。在2119名HCV血清学阴性的器官供体中,我们鉴定出5名HCV RNA阳性供体;在631名HCV血清学阴性的组织供体中,鉴定出1名HCV RNA阳性供体。未鉴定出HIV血清学阴性但HIV RNA阳性的供体。我们的数据表明,对器官和组织供体进行常规核酸检测可能会提高移植中的病毒安全性。